TITAN PHARMACEUTICALS INC — Director's Dealing 2005

Sep 13, 2005

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTP)
CIK: 0000910267
Period of Report: 2005-08-31

Reporting Person: Kapp Joachim Friedrich (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$1.99	2015-09-01	Common Stock (10000)		Direct

Footnotes

F1: These options vest on 9/1/06.